Brief: Creso Pharma Says Unit Entered Consulting Agreement With Canndelta Inc
June 5 (Reuters) - Creso Pharma Ltd CPH.AX :
* UNIT ENTERED CONSULTING AGREEMENT WITH CANNDELTA INC
* DEAL TO MAP EUROPEAN GOOD MANUFACTURING PRACTICE LICENSING
PROCESS FOR ITS MANUFACTURING FACILITY IN NOVA SCOTIA
Source text for Eikon: ID:nASX9lvb7X
Further company coverage: CPH.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Melodiol Global Health
See all newsBrief: Melodiol Global Health Reports Q1 Fy24 Unaudited Revenue Of A$4.8M
Brief: Melodiol Global Health Posts Group Unaudited H1 2024 Revenues Of A$9.3 Mln, Up 33%
Brief: Melodiol Global Health Seeks Trading Halt
Melodiol Global Health gains most in over 7 weeks on Canada asset sale
Brief: Melodiol Global Health Proposes A$12M Cash Asset Sale